129 related articles for article (PubMed ID: 8592129)
1. Antagonism of serotonin 5-HT1A receptors potentiates the increases in extracellular monoamines induced by duloxetine in rat hypothalamus.
Engleman EA; Robertson DW; Thompson DC; Perry KW; Wong DT
J Neurochem; 1996 Feb; 66(2):599-603. PubMed ID: 8592129
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine uptake inhibitor.
Engleman EA; Perry KW; Mayle DA; Wong DT
Neuropsychopharmacology; 1995 Jul; 12(4):287-95. PubMed ID: 7576005
[TBL] [Abstract][Full Text] [Related]
3. Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats.
Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
J Neurochem; 1997 Dec; 69(6):2616-9. PubMed ID: 9375697
[TBL] [Abstract][Full Text] [Related]
4. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.
Koch S; Hemrick-Luecke SK; Thompson LK; Evans DC; Threlkeld PG; Nelson DL; Perry KW; Bymaster FP
Neuropharmacology; 2003 Dec; 45(7):935-44. PubMed ID: 14573386
[TBL] [Abstract][Full Text] [Related]
5. Serum corticosterone increases reflect enhanced uptake inhibitor-induced elevation of extracellular 5-hydroxytryptamine in rat hypothalamus.
Fuller RW; Perry KW; Hemrick-Luecke SK; Engleman E
J Pharm Pharmacol; 1996 Jan; 48(1):68-70. PubMed ID: 8722499
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological characterization of the effect of long-term duloxetine administration on the rat serotonergic and noradrenergic systems.
Rueter LE; De Montigny C; Blier P
J Pharmacol Exp Ther; 1998 May; 285(2):404-12. PubMed ID: 9580577
[TBL] [Abstract][Full Text] [Related]
7. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.
Bymaster FP; Dreshfield-Ahmad LJ; Threlkeld PG; Shaw JL; Thompson L; Nelson DL; Hemrick-Luecke SK; Wong DT
Neuropsychopharmacology; 2001 Dec; 25(6):871-80. PubMed ID: 11750180
[TBL] [Abstract][Full Text] [Related]
8. Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats.
Muneoka K; Shirayama Y; Takigawa M; Shioda S
Neurochem Res; 2009 Mar; 34(3):542-55. PubMed ID: 18751896
[TBL] [Abstract][Full Text] [Related]
9. Effects of milnacipran and pindolol on extracellular noradrenaline and serotonin levels in guinea pig hypothalamus.
Moret C; Briley M
J Neurochem; 1997 Aug; 69(2):815-22. PubMed ID: 9231743
[TBL] [Abstract][Full Text] [Related]
10. 5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex.
Lacroix LP; Dawson LA; Hagan JJ; Heidbreder CA
Synapse; 2004 Feb; 51(2):158-64. PubMed ID: 14618683
[TBL] [Abstract][Full Text] [Related]
11. R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study.
Koch S; Perry KW; Nelson DL; Conway RG; Threlkeld PG; Bymaster FP
Neuropsychopharmacology; 2002 Dec; 27(6):949-59. PubMed ID: 12464452
[TBL] [Abstract][Full Text] [Related]
12. LY248686, a new inhibitor of serotonin and norepinephrine uptake.
Wong DT; Bymaster FP; Mayle DA; Reid LR; Krushinski JH; Robertson DW
Neuropsychopharmacology; 1993 Jan; 8(1):23-33. PubMed ID: 8424846
[TBL] [Abstract][Full Text] [Related]
13. Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats.
Gobert A; Rivet JM; Cistarelli JM; Millan MJ
J Neurochem; 1997 Mar; 68(3):1326-9. PubMed ID: 9048781
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats.
Katofiasc MA; Nissen J; Audia JE; Thor KB
Life Sci; 2002 Aug; 71(11):1227-36. PubMed ID: 12106588
[TBL] [Abstract][Full Text] [Related]
15. Blockade of the serotonin and norepinephrine uptake processes by duloxetine: in vitro and in vivo studies in the rat brain.
Kasamo K; Blier P; De Montigny C
J Pharmacol Exp Ther; 1996 Apr; 277(1):278-86. PubMed ID: 8613930
[TBL] [Abstract][Full Text] [Related]
16. Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex.
Kihara T; Ikeda M
J Pharmacol Exp Ther; 1995 Jan; 272(1):177-83. PubMed ID: 7815331
[TBL] [Abstract][Full Text] [Related]
17. Difference in the in vivo influence of serotonin1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine.
Li XM; Perry KW; Wong DT
Chin J Physiol; 1999 Jun; 42(2):53-9. PubMed ID: 10513599
[TBL] [Abstract][Full Text] [Related]
18. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
Gobert A; Millan MJ
Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
[TBL] [Abstract][Full Text] [Related]
19. Effect of long-term administration of duloxetine on the function of serotonin and noradrenaline terminals in the rat brain.
Rueter LE; Kasamo K; de Montigny C; Blier P
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):600-10. PubMed ID: 9686935
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors.
Dreshfield LJ; Wong DT; Perry KW; Engleman EA
Neurochem Res; 1996 May; 21(5):557-62. PubMed ID: 8726963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
